The under-representation of older people in clinical trials: barriers and potential solutions
- PMID: 18309441
- PMCID: PMC12892591
- DOI: 10.1007/BF02982619
The under-representation of older people in clinical trials: barriers and potential solutions
Abstract
Frail older people are still under-represented in clinical trials. The evidence-base for clinical decision-making in this age group is poor even though older patients are the core business of health services. We examine possible causes for the exclusion of older people from clinical trials and propose possible solutions for this unjust and inequitable situation. Some progress has been made but more needs done to ensure equality and uniformly high standards of health care for older people.
References
-
- Keime-Guibert F, Abellan G, Nourhashemi F, Tsouderos Y, Merdes A, Vellas B. Rational for a minimum data set for clinical trials with geriatric patients. J Nutr Health Aging. 2007;11(3):273–277. PubMed PMID: 17508107. - PubMed
-
- Scottish Executive . Adding Life to Years. Report of the expert group on healthcare of older people. Scottish Executive; Edinburgh: 2002.
-
- Key Health Statistics from General Practice 1998. Analyses of morbidity and treatment data, including time trends, England and Wales. Series MB6 No2. Office for National Statistics
-
- Cancer Statistics registrations. Registrations of cancer diagnosed in 2004, England. Series MBI No35, Office for National Statistics
-
- Cowie MR, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC. Incidence and aetiology of heart failure. A population-based study. European Heart Journal. 1999;20:421–428. 10.1053/euhj.1998.1280 PubMed PMID: 10213345. - DOI - PubMed
Uncited references
-
- CAST (Chinese Acute Stroke Trial) Collaborative Group: randomised placebocontrolled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet. 1997;349:1641–1649. 10.1016/S0140-6736(97)04010-5 - DOI - PubMed
-
- Davis BR, Piller LB, Cutler JA, et al. Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group Role of Diuretics in the Prevention of Heart Failure. Circulation. 2006;113:2201–2210. 10.1161/CIRCULATIONAHA.105.544031 PubMed PMID: 16651474. - DOI - PubMed
-
- The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet. 2003;362:782–788. 10.1016/S0140-6736(03)14286-9 - DOI - PubMed
-
- The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients. N Engl J Med. 2000;342(3):145–153. 10.1056/NEJM200001203420301 - DOI - PubMed
-
- Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, Randomised Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341(10):709–717. 10.1056/NEJM199909023411001 PubMed PMID: 10471456. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
